Healthcare / Health Plans · Utilization Management
Concurrent Review & Length-of-Stay Management
Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.
What You Do Today
UM nurses review inpatient cases daily: applying InterQual or Milliman Care Guidelines (MCG) criteria to determine medical necessity for continued stay, coordinating with attending physicians on discharge planning, identifying patients who no longer meet inpatient criteria (and facilitating transition to observation, SNF, home health, or outpatient), and documenting the clinical rationale for each continued stay day. You manage the appeal process when a payer denies continued stay. LOS management directly impacts hospital finances (DRG (Diagnosis-Related Group)-based reimbursement doesn't increase with extra days), patient throughput, and quality metrics (excess days are associated with complications).
AI Technologies
Roles Involved
How It Works
ML models predict expected LOS at admission based on diagnosis, severity, comorbidities, procedure type, and patient demographics — flagging cases likely to exceed the geometric mean LOS (GMLOS) for their DRG (Diagnosis-Related Group) so UM can engage early. NLP extracts clinical data from nursing assessments, physician progress notes, lab results, and vital sign trends and maps them against InterQual or MCG criteria, pre-populating the review worksheet. Discharge readiness scoring evaluates multiple dimensions (clinical stability, functional status, social determinants, discharge destination availability) to identify patients who are clinically ready but waiting for post-acute placement, transportation, or home setup.
What Changes
Prolonged LOS cases are identified earlier. UM nurse review time per case decreases because criteria matching is pre-populated. Discharge planning starts earlier for predicted long-stay cases. The conversation with attending physicians becomes data-informed ('the model predicts 7 days; we're at day 5 and the patient appears to meet discharge criteria').
What Stays the Same
Clinical judgment on medical necessity remains with the UM nurse and physician advisor. The conversation with the attending about readiness for discharge remains human and requires diplomacy. Appeal processes for payer denials remain human. Physician advisor peer-to-peer reviews remain physician-to-physician. The ethical dimension — ensuring utilization management serves the patient, not just the payer or the hospital's financial interest — requires human judgment.
Cross-Industry Concepts
Evidence & Sources
- •InterQual/Milliman clinical criteria utilization studies
- •URAC utilization management accreditation standards
Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.
Last reviewed: March 2026
What To Do Next
This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.
Establish Your Baseline
Know where you are before you move
Before adopting AI tools for concurrent review & length-of-stay management, document your current state in utilization management.
Without a baseline, you can't tell whether AI actually improved concurrent review & length-of-stay management or just changed who does it.
Define Your Measures
What to track and how to calculate it
patient outcomes
How to calculate
Measure patient outcomes for concurrent review & length-of-stay management before and after AI adoption. Pull from your EHR system.
Why it matters
This is the most direct indicator of whether AI is adding value to utilization management.
clinical documentation quality
How to calculate
Track clinical documentation quality using the same methodology you use today. Don't change how you measure just because you changed how you work.
Why it matters
Speed without quality is just faster mistakes. Measure both together.
Start These Conversations
Who to talk to and what to ask
CMO or VP Clinical Operations
“What's our plan for AI in utilization management? Are we piloting, planning, or waiting?”
This tells you whether to experiment quietly or push for formal investment in concurrent review & length-of-stay management.
your EHR system administrator or vendor
“What AI capabilities exist in our current EHR system that we're not using? Most platforms are adding AI features faster than teams adopt them.”
The cheapest AI adoption is the features already included in your existing license.
a practitioner in utilization management at another organization
“Have you deployed AI for concurrent review & length-of-stay management? What worked, what didn't, and what would you do differently?”
Peer experience is more useful than vendor demos. Find someone who has actually done this.
Check Your Prerequisites
Confirm readiness before you invest
Check items as you confirm them.
More in Utilization Management
Technology That Enables This
These architecture components support or enable this AI application.